课题基金 / 基金详情

Core C: B Cell Core

Core C: B Cell Core
核心C:B细胞核心
批准号:
10731279
负责人:
Kristina De Paris
金额:
$26.78万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2028-03-31

项目摘要

项目成果

Kristina De Paris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – B Cell Core Early development of bNAbs in infants suggest potentially distinct mechanisms in the generation of antibody breadth due to the highly dynamic nature of the infant immune system. Moreover, we have observed elicitation of bNAb precursors in infant rhesus monkeys with germline-targeting HIV Env SOSIP immunization. We hypothesize that induction of bnAb precursor B cells using germline-targeting HIV Env SOSIP immunogens requires specific innate and microbial interactions which are modifiable to enhance future HIV vaccine strategies, particularly in early life. In this context, we propose a B Cell Core that will perform in-depth quantification and characterization of the plasma and B cell responses after BG505 SOSIP GT1.1 immunizations in infant macaques over time through i) the quantification of the functional activity, avidity and target epitope of polyclonal plasma antibody responses (Aim 1) and ii) single cell RNA sequencing of antigen-specific B cell analysis (Aim 2) to evaluate the evolution of vaccine-elicited HIV bNAb precursors and relate these responses to innate immunity (Project 1) and microbial interactions (Project 2). To accomplish this goal, the B Cell Core will draw on the extensive experience and unique resources in antibody and B cell response characterization of the B Cell Core Leader Dr. Marit van Gils at Amsterdam UMC and Dr. Sallie Permar at Weill Cornell Medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative Core
Project 1: The impact of innate immune responses on the development of broadly neutralizing antibodies by vaccination
Project 2: Microbial determinants of HIV broadly-neutralizing antibody precursor induction in infants
Core B: Non-human Primate Core
海外基金